NightHawk Biosciences, Inc. (NHWK) Misses Q2 EPS by 34c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as yields, oil dip
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts NHWK Hot Sheet
Join SI Premium – FREE
NightHawk Biosciences, Inc. (NYSE: NHWK) reported Q2 EPS of ($0.53), $0.34 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $120 thousand.
For earnings history and earnings-related data on NightHawk Biosciences, Inc. (NHWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- CD&R and McKesson to acquire Option Care Health for $5.8B
- RPM International (RPM) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
